Vivos Therapeutics (VVOS) Return on Sales (2020 - 2025)
Historic Return on Sales for Vivos Therapeutics (VVOS) over the last 6 years, with Q3 2025 value amounting to 0.8%.
- Vivos Therapeutics' Return on Sales fell 1200.0% to 0.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.99%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.74% for FY2024, which is 2400.0% up from last year.
- According to the latest figures from Q3 2025, Vivos Therapeutics' Return on Sales is 0.8%, which was down 1200.0% from 1.31% recorded in Q2 2025.
- Over the past 5 years, Vivos Therapeutics' Return on Sales peaked at 0.44% during Q1 2023, and registered a low of 1.69% during Q4 2021.
- Over the past 5 years, Vivos Therapeutics' median Return on Sales value was 1.2% (recorded in 2021), while the average stood at 1.11%.
- Per our database at Business Quant, Vivos Therapeutics' Return on Sales skyrocketed by 11500bps in 2024 and then plummeted by -8400bps in 2025.
- Quarter analysis of 5 years shows Vivos Therapeutics' Return on Sales stood at 1.69% in 2021, then increased by 9bps to 1.54% in 2022, then grew by 14bps to 1.32% in 2023, then surged by 41bps to 0.78% in 2024, then dropped by -2bps to 0.8% in 2025.
- Its last three reported values are 0.8% in Q3 2025, 1.31% for Q2 2025, and 1.28% during Q1 2025.